Royalty bearing license agreement to commercialise a product incorporating the Affimer technology Wetherby and Cambridge, UK, 10 October 2018: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has agreed a commercial license with New England Biolabs® (NEB®) (Ipswich MA, USA), a global leader in the discovery and production of enzymes […]
Menlo Park, CA – Personalis, Inc., a provider of advanced genomic sequencing and analytics for immuno-oncology, today announced an extension to their contract with the US Department of Veterans Affairs (VA) to sequence a further 34,000 whole human genomes for the VA’s Million Veteran Program (MVP). This brings the total of all Personalis contracts from […]
FUJISAWA CITY, Japan & DUBLIN–GenAhead Bio Incorporated (“GenAhead”) and ERS Genomics Limited (“ERS Genomics”) announced today a non-exclusive license agreement to provide GenAhead with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. ERS Genomics holds rights to the foundational CRISPR/Cas9 patent portfolio from Dr. Emmanuelle Charpentier, co-inventor of the breakthrough gene editing technology. GenAhead had its start […]
FDA employs Certara Phoenix®, Simcyp® and Synchrogenix GlobalSubmit software platforms to efficiently assess and evaluate sponsor submissions data PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that the US Food and Drug Administration (FDA) has renewed, and in many cases increased, its number of […]
Ghent, Belgium – Budapest, Hungary | Semantic search company ONTOFORCE and cheminformatics and bioinformatics software solution provider ChemAxon; have set up a collaboration to make it easier to search for linked chemical data. ChemAxon’s web-based molecule drawing and editing tool Marvin JSwill be integrated in ONTOFORCE’s DISQOVER platform. As such, researchers and others will be able to take advantage of […]
Bottmingen — Since 2016, INFORS HT and aquila biolabs have successfully distributed the CGQ for non-invasive online biomass monitoring in shake flasks. In July 2017 both parties have agreed to continue and further expand their partnership. As of today, INFORS HT will additionally distribute aquila biolabs’ LIS. LIS is the first global technology allowing for […]
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)– IQVIA™ (NYSE:IQV) and Genomics England today announced a collaboration to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients. This alliance will enable faster and more efficient drug research, more robust evidence to support treatment value, and greater access […]
Location: Cambridge, UK In vivo study results to be presented at the 2018 SITC Annual Meeting Celyad (Paris:CYAD) (Brussels:CYAD) (NASDAQ:CYAD) (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell-based therapies, today announced an exclusive agreement with Horizon Discovery Group plc (LSE: HZD), for the use […]
Fujisawa, Japan and Dublin, Ireland – Axcelead Drug Discovery Partners, Inc.(hereinafter referred to as “Axcelead”) and ERS Genomics Limited (hereinafter referred to as “ERS Genomics”) announced today a non-exclusive license agreement to provide Axcelead with worldwide access to ERS Genomics’ CRISPR/Cas9 genome editing intellectual property to enhance their drug discovery service offering. ERS Genomics holds rights […]
Combining high-performance automated microfluidics with easy-to-use software to streamline CNV detection for translational and clinical research SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into a non-exclusive distribution agreement with DNA Software, Inc. to provide CopyCount-CNV™ software for use with the Fluidigm Biomark™ HD system. Copy number variation (CNV) plays an important role […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
